11 August 2022
For more than two years, we have been experiencing an exceptional health situation.
This global crisis has thrown the spotlight on our medical system.
Numerous topics were discussed, including :
– Medical and vaccine sovereignty, with the ability to design and produce vaccines and medicines rapidly and in large volumes,
– The efficiency of our healthcare system, with the ability to treat and dispense a vaccine to an entire population as quickly as possible.
Last Tuesday, several national weeklies published an article on defective equipment that necessitated a recall of people vaccinated against monkeypox.
Beyond our ability to obtain and administer vaccines, it is essential to control the risks of a health product’s possible departure from its stability interval, which inevitably leads to reduced or even zero efficacy.
The third subject has been much less visible to the general public: cold chain management. Let’s not forget the first Covid vaccines transported and stored at -80°C. These exceptional constraints led to the creation of 100 “hub centers” and the acquisition of -80°C freezers. But they still have to be transported in the best possible conditions!
In the case of monkeypox, we face the same problems with vaccines that have to be transported, maintained and stored at -80°C, if not for a few days in a household refrigerator.
From day one, ISOVATION, a French designer and manufacturer of isothermal solutions based in Avignon, has wanted to play its part.
ISOVATION has been a partner to the medical community for many years, offering tailor-made isothermal packaging solutions, as well as training for medical staff in the handling and awareness of the risks of cold chain breakdowns.
Our mission is toensure the efficient use of our solutions to meet the medical challenges of today and tomorrow, alongside those who struggle daily to keep our system running: medical sovereignty, quality infrastructures and good control of the cold chain.
Philippe Carles, President of ISOVATION
